Evidence map›Paper›PMID 36094258›Full record

ArticleAntimicrobial agents and chemotherapy2022

Polyimidazolium Protects against an Invasive Clinical Isolate of Salmonella Typhimurium.

Khin K Z Mon, Zhangyong Si, Mary B Chan-Park, Linda J Kenney

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Antibiotics (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Khin K Z MonMechanobiology Institute, National University of Singapore, Singapore, Singapore.ORCID 0000-0001-8656-3944
Zhangyong SiSchool of Chemical and Biomedical Engineering, Nanyang Technological Universitygrid.59025.3b, Singapore, Singapore.
Mary B Chan-ParkSchool of Chemical and Biomedical Engineering, Nanyang Technological Universitygrid.59025.3b, Singapore, Singapore.
Linda J KenneyMechanobiology Institute, National University of Singapore, Singapore, Singapore.ORCID 0000-0002-8658-0717
Nanyang Technological University · SGNational University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Frequent outbreaks of Salmonella Typhimurium infection, in both animal and human populations and with the potential for zoonotic transmission, pose a significant threat to the public health sector. The rapid emergence and spread of more invasive multidrug-resistant clinical isolates of Salmonella further highlight the need for the development of new drugs with effective broad-spectrum bactericidal activities. The synthesis and evaluation of main-chain cationic polyimidazolium 1 (PIM1) against several Gram-positive and Gram-negative bacteria have previously demonstrated the efficacy profile of PIM1. The present study focuses on the antibacterial and anti-biofilm activities of PIM1 against Salmonella in both

Indexed as

Salmonella InfectionsSalmonella Infections, AnimalAnimalsAnti-Bacterial AgentsBiofilmsChick EmbryoChickensGram-Negative BacteriaGram-Positive BacteriaHumansSalmonella typhimuriumAnti-Bacterial AgentsantibiofilmantimicrobialCAMchicken eggpolyimidazoliumSalmonella

Identifiers

PMID36094258
PMCPMC9578408
OpenAlexW4295279388

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.